Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaserc for Vestibular Compensation in Menière's Disease
NCT00160238Phase 4Completed
- Sponsor
- Solvay
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of betahistine in Meniere's disease (MD), sponsored by Solvay. Started Jan 2003; status: completed.
02
Drugs
betahistine
03
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT00160238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160238.